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Simple Summary: Cysteine protease inhibitors (cystatins) are molecules that play key protective
roles in protein degradation and are involved in the immunomodulation of host responses to parasites.
Little is known about the cystatin gene repertoire, evolution, and lineage-specific adaptations of
early-emerging metazoans. Using bioinformatics searches, we identified orthologues of cystatins
in basal animal lineages including free-living and parasite taxa. We aimed to explore whether their
cystatin gene repertoire and evolution follow similar patterns recognized for derived metazoans
and whether the modifications are linked to the organism’s life history. We revealed that cysteine
protease inhibitors from early-emerging animal groups are highly diverse, with modifications in gene
organization and protein architecture. A new subtype of cystatins was discovered in the parasitic
cnidarians, the Myxozoa, which has so far been only reported for a group of derived animals:
trematode flukes. We set out hypotheses to describe the driving forces for the origins of this unique
cystatin subtype and propose evolutionary scenarios elucidating the current existence of cystatins in
the Metazoa, especially in their early-emerging lineages. Our research identified molecules for which
future functional studies may help to identify their roles in host–parasite interactions and for the
parasite itself.
Abstract: The evolutionary aspects of cystatins are greatly underexplored in early-emerging meta-
zoans. Thus, we surveyed the gene organization, protein architecture, and phylogeny of cystatin
homologues mined from 110 genomes and the transcriptomes of 58 basal metazoan species, en-
compassing free-living and parasite taxa of Porifera, Placozoa, Cnidaria (including Myxozoa), and
Ctenophora. We found that the cystatin gene repertoire significantly differs among phyla, with
stefins present in most of the investigated lineages but with type 2 cystatins missing in several
basal metazoan groups. Similar to liver and intestinal flukes, myxozoan parasites possess atypical
stefins with chimeric structure that combine motifs of classical stefins and type 2 cystatins. Other
early metazoan taxa regardless of lifestyle have only the classical representation of cystatins and
lack multi-domain ones. Our comprehensive phylogenetic analyses revealed that stefins and type 2
cystatins clustered into taxonomically defined clades with multiple independent paralogous groups,
which probably arose due to gene duplications. The stefin clade split between the subclades of
classical stefins and the atypical stefins of myxozoans and flukes. Atypical stefins represent key
evolutionary innovations of the two parasite groups for which their origin might have been linked
with ancestral gene chimerization, obligate parasitism, life cycle complexity, genome reduction, and
host immunity.
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1. Introduction
Members of the cystatin superfamily (I25), also known as cystatins, are major regula-
tors of the activity of papain-like cysteine proteases and legumain-type proteases. These
endogenous protease inhibitors are widely distributed in all domains of life. Based on
sequence homology, the cystatin superfamily comprises three main sub-families: types 1–3.
Type 1 cystatins (stefins, I25A) are low-molecular-weight intracellular single-domain pro-
teins generally lacking disulfide bonds and signal peptides. Within the stefins, an additional
subtype, unusually featuring a signal peptide, is recognized exclusively in liver and in-
testinal flukes (Trematoda: Digenea) [1–4]. Type 2 cystatins (I25B) are mainly extracellular
single-domain proteins containing two disulfide bonds and a signal peptide, while type 3
cystatins (kininogens, I25C) are large multi-domain proteins [5–7].
Cystatins are involved in the regulation of key physiological processes, such as the pro-
tection of cells from proteolysis [5–7]. In parasites, cystatins are involved in immunomod-
ulation of host cells and represent important immunogenicity and pathogenicity factors
involved in host–parasite interactions [8–13]. They facilitate parasite survival within the
host [14,15] by inhibiting host proteases and by interfering with antigen processing and pre-
sentation [16–19]. The increased capacity of parasite cystatins to induce anti-inflammatory
cytokine IL-10 [16,17,20] was suggested to be an adaptation to the parasitic lifestyle [21,22].
These molecules have been used as effective markers in diagnosis and vaccine development
and as chemotherapeutic targets against various parasitic infections [23–27]. Recently, cys-
tatins have also been suggested as candidates for immunotherapies for acute and chronic
inflammatory diseases [28] and cancer [29].
The diversity and evolution of the cystatin superfamily is well-documented in prokary-
otes and certain eukaryotic lineages [30–33]. Within the Metazoa, phylogenetic affini-
ties and representation of cystatins have been investigated predominantly in the de-
rived lineages (Bilateria) including both free-living [34] and parasite taxa, e.g., various
helminth [2,10,35–38] and arthropod groups [39–42]. According to the current knowl-
edge of cystatin evolution, the stefin and type 2 cystatin lineages were already present
in the eukaryotic ancestor. Stefins have remained structurally similar to the ancestral
form and are present across most metazoan groups. In contrast, type 2 cystatins greatly
diversified, primarily in derived metazoans (Vertebrata), and have been lost entirely in
some early (Placozoa) and derived (Acoela, Tardigrada, Hemichordata, etc.) metazoan
groups. Multi-domain cystatins have been reported exclusively from several bilaterian
groups [30]. Nevertheless, the picture of cystatin evolution in the Metazoa is incomplete, as
early-emerging animal lineages (Porifera, Ctenophora, Placozoa, and Cnidaria) are greatly
underexplored in this respect and completely underrepresented with regard to parasitic
lineages. To date, only a few early-emerging animal taxa were included in the studies of
cystatin evolution [30,34], from which none were parasites. Thus, further data are needed
from these ancient animal lineages, including those with parasitic lifestyles, to improve our
evolutionary understanding and to explore potential linkage to the organism’s life history.
Basal metazoans mostly comprise free-living species, but at least eight independent
parasite lineages of early-emerging Metazoa are known, with all but one in Cnidaria [43].
Recently, next-generation sequencing (NGS) data have become available for three of these
parasite lineages, i.e., two Edwardsiella spp. [44,45], Polypodium hydriforme [46,47], and
several species of the large group Myxozoa [47–54]. While Edwardsiella and Polypodium
parasitize their hosts exclusively during the larval stage of their development [45,55],
the microscopic myxozoans are an entirely parasitic group with complex life cycles [56].
Members of the specious class Myxosporea are primarily known from fish (intermedi-
ate hosts) and annelids (definitive hosts). The more primitive Malacosporea use fish
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and freshwater bryozoans as hosts [57]. Myxozoans are an evolutionary old and fast-
evolving group, evidenced by their highly derived morphology and seen in genome
phylogenies [46,47,51,53,58]. Their genomes are the smallest amongst all animals due
to evolutionary transition to parasitism and the associated extreme reduction of body
complexity from free-living cnidarians [47].
To explore the gene repertoire, gene organization, and structural features of cystatins
in phyla at the base of the metazoan tree, we mined 110 genomes and transcriptomes
of 58 early-emerging animal species. We conducted phylogenetic analyses using newly
obtained and published cystatin sequences of basal and derived metazoans to provide in-
sights into the origin, evolution, and structural diversification of this group of inhibitors at
the time when this superfamily emerged and expanded. We investigated the amino acid se-
quence structure and phylogenies of cystatins from free-living and parasite taxa to identify
structural modifications, which potentially represent lineage-specific adaptations related to
parasitic lifestyles. Our investigation thus aimed to reveal whether gene repertoire and
evolution of cystatins in early-emerging animals follow similar patterns recognized for
derived metazoans and whether the modifications are linked to the organism’s life history.
2. Materials and Methods
2.1. Data Mining
Representatives of basal metazoan lineages (Placozoa, Porifera, Ctenophora, and
Cnidaria) were selected for mining of cystatin homologues from the NGS data available
from GenBank, other public databases, or produced in our laboratories (110 datasets of
58 species; Table S1). The samples included free-living and parasite taxa, particularly
Cnidaria, i.e., Polypodium hydriforme, Edwardsiella lineata, E. carnea, and all available myxo-
zoans (13 species). We used published the cystatin homologues of metazoans from basal
animal species [30,53] for the cystatin homology search. If no homologues were found
in a species in the first blast, a repeated search was applied by utilizing the sequences
of homologues found in related species in the first iteration as additional queries for the
next search.
We used a combined search strategy using both motif- and sequence similarity-based
methods to identify target molecules. The search was performed using the tBLASTn al-
gorithm with the E-value cutoff set to 10−5. This relatively low threshold was selected
based on low sequence similarity among our queries and subjects (approximately 30–40%).
The mined sequences were examined for the presence of typical conserved motifs of the
cystatin domain (G; Q-x-V-x-G; LP/PW; YF [30,59]), by searches against different databases
(GenBank, MEROPS peptidase database [60]) including the reciprocal blast analysis, and
by their positioning in our preliminary phylogenetic analyses. Detailed homology searches
were performed using the hmmrscan algorithm of HmmerWeb version 2.32.0 software [61]
against protein family databases: Pfam, CATH-Gene3D, PIRSF, Superfamily, TIGRFAM,
and TreeFam. For parasites, the potential contaminating sequences of host or other ori-
gin were identified and filtered out by blast matches with reference NGS data and by
phylogenetic clustering with contaminant species homologues.
2.2. Verification of Selected Cystatin Sequences
Full gene sequences of the cystatin superfamily homologues mined from unpublished
genomes and transcriptomes (Table S1) were verified by PCR and by sequencing from
DNA and/or cDNA templates using species-specific primers designed in this study, if
possible, in the 5’and 3’UTR regions (details in Methods S1 and Table S2). PCR was used
to obtain the stefin gene sequence of Buddenbrockia plumatellae (Methods S1 and Table S2)
as mining of the published Buddenbrockia EST database (Table S1) did not return any
cystatin hits. PCR-verified sequences were deposited in GenBank under the accession Nos.
MT127416–MT127426 and MW498387–MW498390 (Table S2). The positions of the introns
were assessed by comparison of the sequences of DNA vs. cDNA origin and, if possible,
by comparing sequences mined from the genomic vs. transcriptomic data.
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2.3. Phylogenetic Analyses
We compiled and analyzed a sequence dataset (128 taxa) of both newly identified and
published cystatins. The dataset comprised Choanoflagellates (11 taxa), early-emerging
animal lineages (58 taxa), more derived metazoans (58 taxa), and Giardia cystatin (out-
group) resembling the most ancestral eukaryotic cystatin [30] (Table S3). Ingroup taxa
were represented by free-living species (72 taxa) and parasite species from basal meta-
zoans (Polypodium hydriforme, Edwardsiella spp., and myxozoans; 16 taxa) and bilaterians
(trematodes, cestodes, nematodes, monogeneans, ticks, and mites; 39 taxa) (Table S3).
Multi-domain cystatins were omitted from the phylogenetic analyses due to difficulties
with their alignment.
We aligned 329 amino acid cystatin sequences in MAFFT v7.017 implemented in
Geneious v8.1.3 [62] using the iterative refinement by the G-INS-i strategy that resulted
in an alignment of stefins and type 2 cystatins according to topological equivalence in
tertiary structure (see Dataset S1 of [59]). Nonhomologous regions at the beginning (e.g.,
signal peptides) and end of the alignment were trimmed so the final alignment com-
prised 213 positions, principally corresponding to the conserved cystatin domain (Pfam:
PF00031) (Dataset S2). The phylogenetic trees were reconstructed using the maximum
likelihood (ML) and Bayesian inference (BI) methods. ML analysis was performed in
RAxML v7.0.3 [63], using the WAG + G model selected by ModelFinder implemented in
IQ-TREE webserver [64]. Indels were treated as unknown characters. Bootstraps were
based on 1000 replicates. BI analysis was performed in MrBayes v3.2.7av1 [65] using the
WAG model of evolution, with 24 million generations sampled at intervals of 1000 trees
until the standard deviation from split frequencies was below 0.05. The burn-in period
represented the default initial 25% of all generations. The trees were visualized in Geneious
v8.1.3 and graphically modified in Adobe Illustrator CS5.
2.4. Comparison of the Protein Architecture
Cystatin diversity on the amino acid sequence level was analyzed in terms of critical
motifs, amino acid conservation, presence/absence of a signal peptide and disulfide
bridges, and modifications that might potentially affect the cystatin inhibitory activity.
Disulfide bonds were predicted using the DISULFIND webserver [66]. Signal peptides
were predicted using the SignalP v5.0 webserver [67]. Animal group-/cystatin type-specific
sequence motifs were identified by comparison of primary structures of cystatin amino
acid sequences in the WebLogo v3 software [68] using extractions of the alignment used
for the phylogenetic analyses.
3. Results
In this study, we retrieved 184 homologues of cystatins (104 stefins and 80 type 2
cystatins) from the NGS data of early-emerging metazoans (Table S1). Of these, we verified
with PCR the identity of 15 homologues mined from unpublished datasets (Table S2).
3.1. Cystatin Gene Repertoire and Diversity in Early-Emerging Metazoans
We observed a large variation in the representation of cystatin subclasses in the
investigated animal groups (Figure 1). Type 2 cystatins were missing in several groups
(Placozoa, Porifera, Cnidaria: Staurozoa, and Myxozoa). Stefins were present in all but
one (Placozoa) basal metazoan lineage. We found a separate group of stefins in myxozoan
parasites, designated here as “atypical stefins”, which differed in sequence structure to
classical metazoan stefins (see Section 3.3 and Figure 2). No multi-domain cystatins could
be identified in basal metazoans (Figure 1).
Biology 2021, 10, 110 5 of 16
Biology 2021, 10, x 5 of 17 
 
 
We observed a large variation in the representation of cystatin subclasses in the in-
vestigated animal groups (Figure 1). Type 2 cystatins were missing in several groups 
(Placozoa, Porifera, Cnidaria: Staurozoa, and Myxozoa). Stefins were present in all but 
one (Placozoa) basal metazoan lineage. We found a separate group of stefins in myxozoan 
parasites, designated here as “atypical stefins”, which differed in sequence structure to 
classical metazoan stefins (see Section 3.3 and Figure 2). No multi-domain cystatins could 
be identified in basal metazoans (Figure 1). 
 
Figure 1. Repertoire of cystatin superfamily genes in early-emerging metazoan lineages. 
 
Figure 2. Schematic comparison of the gene architecture and amino acid structure of metazoan 
cystatins: for myxozoans, information is shown separately for Malacosporea and Myxosporea. 
We found that basal metazoans had a diverse cystatin gene repertoire: most investi-
gated species had multiple cystatin homologues with significant sequence differences, 
even on the intraspecies level (i.e., several divergent sequences of type 2 cystatin and/or 
Figure 1. Repertoire of cystatin superfamily genes in early-emerging metazoan lineages.
Biology 2021, 10, x 5 of 17 
 
 
We observed a large variation in the representation of cystatin subclasses in the in-
vestigated animal groups (Figure 1). Type 2 cystatins were missing in several groups 
(Placozoa, Porifera, Cnidaria: Staurozoa, and Myxozoa). Stefins were present in all but 
one (Placozoa) basal metazoan lineage. We found a separate group of stefins in myxozoan 
parasites, designated here as “atypical stefins”, which differed in sequence structure to 
classical metazoan stefins (see Section 3.3 and Figure 2). No multi-domain cystatins could 
be identified in basal metazoans (Figure 1). 
 
Figure 1. Repertoire of cystatin superfamily genes in early-emerging metazoan lineages. 
 
Figure 2. Sche atic comparison of the gene architecture and amino acid structure of metazoan 
cystatins: for myxozoans, information is shown separately for Malacosporea and Myxosporea. 
We found that basal metazoans had a diverse cystatin gene repertoire: most investi-
gated species had multiple cystatin homologues with significant sequence differences, 
even on the intraspecies level (i.e., several divergent sequences of type 2 cystatin and/or 
Figure 2. Schem tic comparis n of the gene architecture a d amino acid structure of met zoan cystatins: for myxozoans,
information is shown separately for Malacosporea and Myxosporea.
We found that basal etazoans had a diverse cy tatin gene repertoire: most investi-
gated sp cies had multipl cystatin homologues with significant sequence differences, even
on the intraspecies level (i.e., several divergent sequences of type 2 cystatin and/or stefin
homologues in the genome of a single species; Table S1). Exceptionally, certain species
(e.g., cnidarians Ceratonova shasta and Physalia physalis) only possessed single type 2 cystatin
and/or stefin homologue.
All mined cystatin homologues are listed either as new GenBank entries (for PCR-
verified sequences mined from data unpublished at the time of the homology searches) or
as Genbank contig/scaffold identifiers for sequences mined from published data (Table S2
and Dataset S1).
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3.2. Phylogeny of Metazoan Cystatins did not Mirror Animal Phylogeny and Was Highly Diverse
within Individual Groups
The clustering of cystatins in both ML and BI analyses did not follow the generally ac-
cepted trends of organismal phylogeny, as early-emerging animal lineages did not occupy
basal positions in our trees (Figure 3 and Figure S1) as commonly known from other phylo-
genetically informative genes., e.g., 18S rDNA. Based on differences in the primary amino
acid sequence structure, cystatins clustered into a single weakly supported stefin clade
(ML/BI = 48/0.75) while the remainder of sequences clustered within the type 2 cystatin
clade (ML/BI = 59/0.92). The stefin clade included a mixture of classical and atypical stefin
subclades with weakly supported interrelationships. Classical stefin subclades comprised
all Metazoa except the myxozoans, while atypical stefin subclades were formed exclusively
of certain early-emerging (myxozoans) and more derived (trematodes) parasite animal
lineages. Unlike other metazoan stefins, those of myxozoans were extremely divergent in
their sequences, thus creating long branches (Figure 3 and Figure S1).
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The detailed ML and BI phylogenetic trees featuring taxa names and all nodal supports are provided in Figure S1.
Both stefins and type 2 cystatins clustered into subclades that paralleled classic taxon-
omy. However, interclade relationships of these taxonomy-defined subclades were weakly
supported/not resolved due to polytomies (Figure 3 and Figure S1) and did not always
reflect the organismal phylogeny. Indeed, some representatives formed monophyletic taxo-
nomic groups, e.g., Ctenophora, Porifera, Cubozoa, and Myxozoa, while some cnidarian
Biology 2021, 10, 110 7 of 16
groups (Polypodiozoa, Staurozoa, Scyphozoa, Anthozoa, and Hydrozoa) split into multiple
subclades not related by classic taxonomy. We attributed this splitting to (i) sequence dif-
ferences among species of the same taxonomic group (e.g., hydrozoans Hydra, Podocoryna,
Physalia, Velella, and Porpita spp. clustering into independent type 2 cystatin clades) or (ii)
the occurrence of paralogues (e.g., stefin out-paralogues of the scyphozoan Aurelia aurita
present in two distinct groups). Some of the out-paralogous clades additionally contained
multiple sequences from single species (e.g., stefin in-paralogues of A. aurita ranging up to
37.7% amino acid sequence divergence) (Figure 3 and Figure S1).
3.3. Structural Modifications of Cystatin Homologues in Basal Metazoans
The results of structural analyses aimed at identifying intron number and positions,
conserved regions, and the presence/absence of signal peptides and cysteine bonds were
combined to create the comparative scheme of cystatin structural motifs (Figure 2).
We identified that introns in cystatin nucleotide sequences of early-emerging animal
lineages varied in number (0–2) and location in type 2 cystatins while stefins contained two
introns with conserved positions (Figure 2). All introns were delimited by typical GT/AG
sequence boundaries at the exon–intron junction.
In amino acid sequence data from our alignment of basal animals (Dataset S2), we
observed four conserved regions important for interaction with proteases, as found pre-
viously with derived metazoans [30,59]: (i) a glycine residue within the amino-terminal
“trunk”, (ii) a Q-x-V-x-G motif within the first hairpin loop, (iii) the PW (type 2 cystatins) or
LP (stefins) motifs within the second hairpin loop, and (iv) a tyrosine residue located in
the relatively conserved D-x-L-x-Y-F carboxy terminus of stefins. We observed two novel
conserved residues in stefins of both early-emerging and derived metazoans: (i) a histidine
residue located seven amino acids before the LP pair towards the N-terminus and (ii) a
lysine residue situated eight amino acids before the C-terminal conserved tyrosine residue
(Figure 2 and Dataset S2).
While the amino acid structure of the first two key activity regions (G, Q-x-V-x-G)
was conserved among all sequences, several modifications were seen in other regions. All
sponge (Porifera) stefins showed a characteristic amino acid replacement of the LP pair to
LD (or LS in one case). Substitution of the conserved C-terminal tyrosine residue by non-
aromatic valine was observed in two homologues. The conserved histidine residue located
near the LP pair was commonly replaced by methionine or, exceptionally, by histidine or
tryptophan (both observed once) (Dataset S2).
Stefins and type 2 cystatins of comb jellies (Ctenophora) had the typical sequence
motifs defined for these molecules in other metazoans. In a few taxa, we observed substitu-
tions of the conserved cystatin PW pair by AW and stefin C-terminal tyrosine residue by
proline or histidine (Dataset S2).
Cnidarian cysteine protease inhibitors showed a wide variety of modifications (Figure 2
and Dataset S2). Cubozoans were the only group for which conserved stefin regions had
the classical organization, and their type 2 cystatins differed in a few cases by replacement
of the PW motif with SW or KF. Stefins of hydrozoans and scyphozoans showed single
substitutions of LP to FA or LK and single alterations of C-terminal tyrosine to aromatic
phenylalanine, and many of the type 2 cystatins had substitutions of PW with AW, RW,
or SW and exceptionally with PF or PL. Staurozoan stefins had C-terminus modifications,
where the tyrosine residue was substituted with histidine or was missing. In anthozoans,
type 2 cystatins had alterations of PW to SW or GW, while a few stefins had substitutions of
LP with FD or FS and replacement of the C-terminal tyrosine residue to proline or histidine.
The most notable modification we found was in two parasitic cnidarian groups Poly-
podiozoa and Myxozoa. While the majority of type 2 cystatins of P. hydriforme had the
typical conserved motifs, its stefin was highly modified, with the LP pair substituted with
LS and the C-terminal conserved D-x-L-x-Y-F motif replaced with a completely different
pattern lacking a tyrosine residue. While this stefin retained the histidine found near the LP
pair, the conserved lysine located near the C-terminal was replaced by leucine. Myxozoans,
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as representatives of early-emerging metazoans, had atypical stefins, which completely
lacked the D-x-L-x-Y-F region at the C-terminus and had the normally conserved histidine
and lysine residues replaced by other residues. Stefins of an evolutionary older myxozoan
subgroup, the Malacosporea, retained the original LP pair, but some stefins of the specious
and more derived myxozoan group, the Myxosporea, had replaced this motif with LS,
LY, LR, FK, or SA (Figure 2). We could not find classical stefins or type 2 cystatins in any
myxozoan (Figure 1).
In general, signal peptides in cystatins of basal metazoan lineages followed estab-
lished patterns: they were present in type 2 cystatins and absent in classical stefins. The
only exceptions were some myxosporean stefins that carried a signal peptide (Figure 2).
Interestingly, the pattern of signal peptide absence (in type 1 atypical stefins) or presence
(in type 2 atypical stefins) was observed even at the intraspecies level. For example, some
myxosporeans coded exclusively for stefins without a signal peptide (i.e., C. shasta and
Sphaeromyxa zaharoni) while others presented multiple stefin genes that all carried the
signal peptide (i.e., Myxobolus pendula and M. cerebralis) or had genes that represented
both variations (i.e., Enteromyxum leei, E. scophthalmi, Kudoa iwatai, Thelohanellus kitauei,
Myxidium lieberkuehni and Sphaerospora molnari) (Figure 2 and Dataset S1).
As typical for type 2 cystatins, two conserved disulfide bridges were identified in all
basal metazoans with the exception of homologues found in ctenophorans, which were
predicted to contain only one disulfide bridge. Classical stefins lacked disulfide bridges, as
is typical for this cystatin subfamily type, and this pattern was also observed in atypical
stefins (Figure 2).
3.4. Structural and Evolutionary Comparison of Cystatins of Parasitic vs. Free-Living Groups of
Basal Metazoans: The Special Case of Myxozoa
The Myxozoa, the only obligate parasite group of early-emerging metazoans, pos-
sessed exclusively atypical stefins and lacked type 2 cystatins. Myxozoan stefins had
characteristic differences in sequence to those of the other basal Metazoa (see Section 3.3)
and clustered into a single clade with long branches (see Section 3.2). The two cnidar-
ian lineages studied that are parasitic only in their larval stage (E. lineata, E. carnea, and
P. hydriforme) possessed both classical stefins and type 2 cystatins, and no atypical stefins
were found in these animals. Their stefins formed a distinct lineage that afterwards clus-
tered with other cnidarians (P. hydriforme) or grouped with their respective anthozoan
members (E. lineata and E. carnea). Similarly, clustering of “partially parasitic” cnidarians
into distinct monotypic lineages (P. hydriforme) or within anthozoan lineages (E. lineata
and E. carnea) was observed for type 2 cystatins (Figure 3 and Figure S1). No structurally
unique molecules were identified in the entirely free-living basal metazoans.
4. Discussion
4.1. A Diverse Repertoire of Cystatins in Early-Emerging Metazoans
In this study, we identified the cystatin gene repertoire of early-emerging animals by
mining homologues from 110 genomes and transcriptomes of basal Metazoa. We demon-
strate that cystatins are widely distributed and highly diversified in current representatives
of these ancient lineages and that the repertoire of cystatin superfamily genes differs widely
among phyla. Each taxonomic group evolved multiple stefin and/or type 2 cystatin homo-
logues, forming individual taxonomy-defined clades in the phylogeny. These paralogues
probably arose by gene duplication [30] rather than by whole genome multiplication, as
the only basal metazoans for which genome duplication has been suggested are mem-
bers of the cnidarian genus Acropora [69]. Multiple out-paralogues found in cnidarians
likely originated before cnidarian radiation while, in-paralogues, probably emerged after
the speciation event. Bursts of sequence diversification likely gave rise to gene ortho-
logues within each taxonomy-defined clade. These evolutionary processes resulted in the
origin of diverse molecules with varying inhibitory and immunomodulatory functions
in metazoans.
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Some taxonomic groups had a wide diversity of cystatins, while others lacked some or
all cystatin subfamilies. For example, genes coding for cystatins were not identified in the
placozoan genomes: two different strains of Trichoplax sp. [70] and Hoilungia hongkongensis [71],
which was in concordance with findings of Kordiš and Turk [30] from the related species
Trichoplax adhaerens [70,72]. Evidently, cystatins are not essential for the survival of these
simple organisms despite the presence of cysteine proteases in them [71,72]. We sug-
gest that, in placozoans, the functions of cystatins have been replaced by other types of
inhibitors, such as structurally unrelated equistatin or serpins [70–72]. These proteins
have been recognized in other organisms as potent inhibitors of cysteine proteases [73] or
cross-class inhibitors of them [74].
4.2. Atypical Stefins: A Unique Type of Cystatins in Myxozoans and Some Trematodes
Interestingly, we found a wide diversity of both classical and atypical stefins in basal
metazoans and we suspect that these highly divergent homologues may have different or
novel functions, as suggested for the highly divergent myxozoans serpins (serine protease
inhibitors [75]). Stefins structurally similar to those of myxozoans have been identified only
from more derived bilaterians: intestinal and liver flukes (Trematoda: Digenea) [1–4]. While
myxozoans possess only atypical stefins, these trematodes have cystatins from several
superfamily subclasses (classical and atypical stefins, multi-domain cystatins [1–4,22,76]).
The atypical stefins presumably arose independently in the two groups, possibly as a result
of pressures from a parasitic life history; however, other parasites do not possess these
molecules. For example, parasitic metazoans (monogeneans, nematodes, cestodes, ticks,
and mites) [9,36,37,39,42] including blood trematodes [35] have only classical stefins and
type 2 cystatins. Similarly, cnidarians Polypodium and Edwardsiella spp. with parasitic larval
and free-living adult stages also have only classical stefins and type 2 cystatins. Thus,
atypical stefins represent key evolutionary innovations of myxozoans and intestinal and
liver trematodes. The likely function of atypical stefins in myxozoans and trematodes is
to control unwanted proteolysis by cysteine proteases expressed by different parasite life
stages and by the host [1].
Structurally, atypical stefins contain the characteristic stefin LP pair, which is modified
in certain myxozoan stefins. Importantly, all atypical stefins lack the conserved D-x-L-x-
Y-F carboxy-terminal part that is generally found in classical stefins but is absent from
type 2 cystatins (Figure 2). As the tyrosine residue of the D-x-L-x-Y-F region is important
for stabilization of the stefin-protease complex [59,77], the absence of this motif along with
the modifications in the conserved LP pair may have functional implications in atypical
stefins, e.g., their capability to inhibit a broader range of proteases, including those of host
origin. The function of this C-terminal modification warrants future experimental studies
as demonstrated previously for stefin mutants [77,78].
Additionally, we identified that the atypical stefins of some myxozoans and all trema-
todes have a signal peptide typical for type 2 cystatins (Figure 2). In some taxa, this
feature correlates with extracorporeal protein secretion [3,79–81], but this is not consistent
across the Metazoa, as not all proteins that have a signal peptide are exported out of the
organism [1] and a large proportion of excreted/secreted products do not have a signal
peptide [1,4,37,79,81–83]. Secreted proteins, including cystatins, are crucial for parasite
protection from degradation by host cysteine proteases and for modulation of host immu-
nity [9–11,16,79]. We postulate that some myxozoan stefins are secretory proteins with
immunomodulatory roles, as has been suggested for the atypical stefin of the myxosporean
Thelohanellus kitauei [53,84]. These molecules are likely responsible for the increased expres-
sion of the anti-inflammatory IL-10 gene in fish hosts infected with different myxosporean
species [85–90] as an increased production of IL-10 in hosts infected by other parasites is
elicited by cystatin-induced immunomodulation [16,20]. Similar to other parasites [23–27],
we suggest that these proteins should be further explored in myxozoans as vaccine targets
due to the lack of efficient strategies against these parasites in fish destined for human
consumption [91,92].
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We propose two mechanisms for the origin of atypical stefins: (i) structural modifica-
tion of ancestral classical stefins by the acquisition of a signal peptide in some homologues
and loss of the C-terminal and its tyrosine residue, or (ii) combination of the features of
classical stefins (LP pair) and type 2 cystatins (signal peptides, missing C-terminal part)
in chimeric genes. Chimeric genes are important in the evolution of genetic novelty and
can allow organisms to adapt to novel environments (or hosts) by acquisition of novel
functions [93,94]. Both myxozoans and trematodes are obligate parasites with complex
life cycles that involve vertebrate and invertebrate hosts [8,95]. The independent origins
of their atypical stefins might have been associated with the transition of a presumably
free-living ancestor to obligate parasitism and the associated challenges of surviving within
one or more hosts. Extending a recent hypothesis that invertebrates were the initial hosts
for myxozoans and fish were incorporated into life cycles later [96], we postulate that
myxozoans reduced their type 2 cystatins in the invertebrate host in the course of genome
reduction due to parasitism [47] since invertebrates have limited immune capacity [97].
Ancestral superfamily cystatin types were lost in myxozoans as their roles were replaced
by atypical stefins, which in trematodes have been shown to inhibit both parasite and host
proteases [2,3]. Then, under novel pressures in adopted fish hosts, myxozoans remodeled
classical stefins into the atypical ones to interfere with specific immune responses of fish
and to enable novel behaviors such as migration within host tissues.
4.3. Obstacles to Reconstruction of Cystatin Phylogenies
In our analyses, the reconstruction of evolutionary relationships in the cystatin super-
family had good support for the more recent clades but not for deeper evolutionary nodes,
as reported previously for this group of genes [30,35]. Unstable topology, polytomies (in
BI), and low nodal supports in our phylogeny were due to low informative content from
short protein length and high sequence divergence in the chosen genes [30,35]. However,
despite generally poor support, a clear separation of ingroup taxa into distinct lineages
defined by taxonomy and protein architecture revealed remarkable trends in the evolution
of cystatins in early-emerging metazoans, with structurally unique molecules of potentially
novel functions. Different branches appear to have evolved at different rates [98], espe-
cially in fast-evolving myxozoans [46,47,51,53,58]. Fast rates of evolution of the myxozoan
genes likely caused the extraordinary sequence divergence of myxozoan stefins, which
may represent functional diversification of these molecules. Phylogenetic clustering of
atypical stefins within the myxozoan clade seems to some extent to follow myxozoan speci-
ation and differentiation into the well-known myxozoan lineages (oligochaete-infecting,
polychaete-infecting, Sphaerospora sensu stricto, and malacosporeans [96]) Resolution of
these established myxozoan clades is low due to the undersampling of taxa and is probably
compounded by diversification including a wide functional range of atypical stefins, with
or without signal peptides, and with each particular lineage displaying specific sequence
motifs and potential host organ-specific protease expression.
4.4. Hypothetical Evolution of Metazoan Cystatins
From their comprehensive analysis of prokaryotic and eukaryotic cystatins, Kordiš
and Turk [30] concluded that the ancestor of the cystatin superfamily was intracellular
and lacked a signal peptide and disulfide bridges (similarly to extant stefins). Initial gene
duplication produced two ancestral eukaryotic lineages, stefins and type 2 cystatins, with
the latter evolving from the stefin-like ancestor by acquiring cysteine residues, disulfide
bridges, and a signal peptide. Later gene and domain duplications combined with deletions
and insertions of genetic material resulted in diverse single- and multi-domain proteins
with or without disulfide bonds and glycosylations [30].
Based on our novel data and published records [30], we propose the following al-
ternative scenarios for the evolution of single-domain cystatins in the Metazoa, with a
focus on its basal lineages (Figure 4). After the split of the cystatin superfamily into the
initial stefin and type 2 cystatin lineages in the ancestor of eukaryotes, stefins were retained
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in the common ancestor of the Metazoa and all its descendant lineages except Placozoa.
Sequence diversification and lineage-specific adaptation of stefins occurred independently
in parasites (Myxozoa and Trematoda), giving rise to atypical stefins. Type 2 cystatins
were either (i) retained in the metazoan ancestor and its descendant lineages except for
their independent loss in Porifera, Placozoa, some Cnidaria (Myxozoa, Staurozoa) and
some bilaterians (liver and intestinal flukes) (scenario A in Figure 4); (ii) initially lost in the
metazoan ancestor (or even before), reappeared in the ancestor of Eumetazoa, and were
again lost in some descendant lineages (Placozoa, Myxozoa, Staurozoa, and some flukes)
(scenario B in Figure 4); or (iii) initially lost in the metazoan ancestor (or even before) and
reappeared independently in Ctenophora and in the ancestor of the lineage, leading to
Cnidaria and Bilateria with some groups (Myxozoa, some flukes) having a secondary loss
(scenario C in Figure 4).




Figure 4. Hypothetical evolutionary scenarios of origins of stefins and type 2 cystatins in the Meta-
zoa with a focus on early-emerging animal lineages: please note that the different colors for type 2 
cystatins visualize the alternative scenarios of hypothetical evolution for the same cystatin subtype 
and not the sequence differences. 
5. Conclusions 
Stefins are considered relatively conserved genes with characteristics closer to the 
ancestral superfamily type, while type 2 cystatins are considered to have undergone a 
more complex and dynamic evolution through numerous gene and domain duplications 
[30]. In this study, we showed that early-emerging metazoan lineages were more prone to 
type 2 cystatin loss and that significant diversification of this type of molecules occurred 
only later in their evolution. Simultaneously, these ancient lineages retained stefin genes 
that were more dynamic with regard to structural modifications, with bursts of diversifi-
cation creating atypical stefins in some obligate parasites with complex life cycles. Further 
research aimed at biochemical and functional characterization of the parasite cysteine pro-
tease inhibitors, especially of atypical stefins, is necessary to decipher the roles of these 
proteins in multi-host–parasite interactions. This knowledge will improve the under-
standing of the contributions of cystatins for parasite survival in the host causing disease 
and may reveal targets for therapeutant development against Myxozoa. 
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, Figure S1: 
Maximum likelihood and Bayesian trees with nodal supports; Table S1: Next-generation sequencing 
Figure 4. Hypothetical evolutionary scenarios of origins of stefins and type 2 cystatins in the Metazoa
with a focus on early-emerging animal lineages: please note that the different colors for type 2
cystatins visualize the alternative scenarios of hypothetical evolution for the same cystatin subtype
and not the sequence differences.
5. Conclusions
Stefins are considered relatively conserved genes with characteristics closer to the
ancestral superfa ily type, while type 2 cystatins are considered to have undergone a more
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complex and dynamic evolution through numerous gene and domain duplications [30]. In
this study, we showed that early-emerging metazoan lineages were more prone to type 2
cystatin loss and that significant diversification of this type of molecules occurred only
later in their evolution. Simultaneously, these ancient lineages retained stefin genes that
were more dynamic with regard to structural modifications, with bursts of diversification
creating atypical stefins in some obligate parasites with complex life cycles. Further research
aimed at biochemical and functional characterization of the parasite cysteine protease
inhibitors, especially of atypical stefins, is necessary to decipher the roles of these proteins
in multi-host–parasite interactions. This knowledge will improve the understanding of the
contributions of cystatins for parasite survival in the host causing disease and may reveal
targets for therapeutant development against Myxozoa.
Supplementary Materials: The following are available online at https://www.mdpi.com/2079-773
7/10/2/110/s1, Figure S1: Maximum likelihood and Bayesian trees with nodal supports; Table S1:
Next-generation sequencing databases mined for cystatins; Table S2: List of myxozoan species
with information on primers used for the PCR verification of stefin genes; Table S3: The list of
groups/species used for phylogenetic analyses. Methods S1: Methodological details regarding the
PCR verification of myxozoan stefins; Dataset S1: Fasta file of complete the amino acid sequences of
cystatins present in the phylogenetic analyses; Dataset S2: Fasta-formatted alignment of the trimmed
amino acid sequences of cystatins used for the phylogenetic analyses.
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wide comparisons and virulence gene polymorphisms of host-associated genotypes of the cnidarian parasite Ceratonova shasta in
salmonids. Genome Biol. Evol. 2020, 12, 1258–1276. [CrossRef]
51. Nesnidal, M.; Helmkampf, M.; Bruchhaus, I.; El-Matbouli, M.; Hausdorf, B. Agent of whirling disease meets orphan worm:
Phylogenomic analyses firmly place Myxozoa in Cnidaria. PLoS ONE 2013, 8, e54576. [CrossRef]
52. Foox, J.; Ringuette, M.; Desser, S.S.; Siddall, M.E. In silico hybridization enables transcriptomic illumination of the nature and
evolution of Myxozoa. BMC Genom. 2015, 16, 840. [CrossRef] [PubMed]
53. Yang, Y.L.; Xiong, J.; Zhou, Z.G.; Huo, F.M.; Miao, W.; Ran, C.; Liu, Y.C.; Zhang, J.Y.; Feng, J.M.; Wang, M.; et al. The genome
of the myxosporean Thelohanellus kitauei shows adaptations to nutrient acquisition within its fish host. Genome Biol. Evol. 2014,
6, 3182–3198. [CrossRef] [PubMed]
54. Hartigan, A.; Kosakyan, A.; Pecková, H.; Eszterbauer, E.; Holzer, A.S. Transcriptome of Sphaerospora molnari (Cnidaria, Myx-
osporea) blood stages provides proteolytic arsenal as potential therapeutic targets against sphaerosporosis in common carp.
BMC Genom. 2020, 21, 404. [CrossRef] [PubMed]
55. Evans, N.M.; Lindner, A.; Raikova, E.V.; Collins, A.G.; Cartwright, P. Phylogenetic placement of the enigmatic parasite,
Polypodium hydriforme, within the Phylum Cnidaria. BMC Evol. Biol. 2008, 8, 139. [CrossRef] [PubMed]
56. Okamura, B.; Gruhl, A. Myxozoan affinities and route to endoparasitism. In Myxozoan Evolution, Ecology and Development;
Okamura, B., Gruhl, A., Bartholomew, J.L., Eds.; Springer: Cham, Switzerland, 2015; pp. 23–44.
57. Fiala, I.; Bartošová-Sojková, P.; Okamura, B.; Hartikainen, H. Adaptive radiation and evolution within the Myxozoa. In Myxozoan
Evolution, Ecology and Development; Okamura, B., Gruhl, A., Bartholomew, J.L., Eds.; Springer: Cham, Switzerland, 2015; pp. 69–84.
58. Feng, J.M.; Xiong, J.; Zhang, J.Y.; Yang, Y.L.; Yao, B.; Zhou, Z.G.; Miao, W. New phylogenomic and comparative analyses provide
corroborating evidence that Myxozoa is Cnidaria. Mol. Phylogenet. Evol. 2014, 81, 10–18. [CrossRef]
Biology 2021, 10, 110 15 of 16
59. Stubbs, M.; Laber, B.; Bode, W.; Huber, R.; Jerala, R.; Lenarcic, B.; Turk, V. The refined 2.4A X-ray crystal structure of recombinant
human stefin B in complex with the cysteine proteinase papain: A novel type of proteinase inhibitor interaction. EMBO J. 1990,
9, 1939–1947. [CrossRef]
60. Rawlings, N.D.; Alan, J.; Thomas, P.D.; Huang, X.D.; Bateman, A.; Finn, R.D. The MEROPS database of proteolytic enzymes,
their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database. Nucleic Acids Res. 2018,
46, D624–D632. [CrossRef]
61. Potter, S.C.; Luciani, A.; Eddy, S.R.; Park, Y.; Lopez, R.; Finn, R.D. HMMER web server: 2018 update. Nucleic Acids Res. 2018, 46,
W200–W204. [CrossRef]
62. Kearse, M.; Moir, R.; Wilson, A.; Stones-Havas, S.; Cheung, M.; Sturrock, S.; Buxton, S.; Cooper, A.; Markowitz, S.; Duran, C.
Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data.
Bioinformatics 2012, 28, 1647–1649. [CrossRef] [PubMed]
63. Stamatakis, A. RAxML version 8: A tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 2014,
30, 1312–1313. [CrossRef]
64. Trifinopoulos, J.; Nguyen, L.T.; von Haeseler, A.; Minh, B.Q. W-IQ-TREE: A fast online phylogenetic tool for maximum likelihood
analysis. Nucleic Acids Res. 2016, 44, W232–W235. [CrossRef] [PubMed]
65. Ronquist, F.; Teslenko, M.; van der Mark, P.; Ayres, D.L.; Darling, A.; Höhna, S.; Larget, B.; Liu, L.; Suchard, M.A.; Huelsenbeck, J.P.
MrBayes 3.2: Efficient Bayesian phylogenetic inference and model choice across a large model space. Syst. Biol. 2012,
61, 539–542. [CrossRef] [PubMed]
66. Ceroni, A.; Passerini, A.; Vullo, A.; Frasconi, P. DISULFIND: A disulfide bonding state and cysteine connectivity prediction server.
Nucleic Acids Res. 2006, 34, W177–W181. [CrossRef] [PubMed]
67. Almagro Armenteros, J.J.; Tsirigos, K.D.; Sønderby, C.K.; Petersen, T.N.; Winther, O.; Brunak, S.; von Heijne, G.; Nielsen, H. SignalP
5.0 improves signal peptide predictions using deep neural networks. Nat. Biotechnol. 2019, 37, 420–423. [CrossRef] [PubMed]
68. Crooks, G.E.; Hon, G.; Chandonia, J.M.; Brenner, S.E. WebLogo: A sequence logo generator. Genome Res. 2004, 14, 1188–1190.
[CrossRef] [PubMed]
69. Mao, Y.F.; Satoh, N. A likely ancient genome duplication in the speciose reef-building coral genus, Acropora. Iscience 2019,
13, 20–32. [CrossRef] [PubMed]
70. Kamm, K.; Osigus, H.J.; Stadler, P.F.; DeSalle, R.; Schierwater, B. Trichoplax genomes reveal profound admixture and suggest
stable wild populations without bisexual reproduction. Sci. Rep. 2018, 8, 11168. [CrossRef] [PubMed]
71. Eitel, M.; Francis, W.; Varoqueaux, F.; Daraspe, J.; Osigus, H.; Krebs, S.; Vargas, S.; Blum, H.; Williams, G.; Schierwater, B.; et al.
Comparative genomics and the nature of placozoan species. PLoS Biol. 2018, 16, e3000032. [CrossRef]
72. Srivastava, M.; Begovic, E.; Chapman, J.; Putnam, N.; Hellsten, U.; Kawashima, T.; Kuo, A.; Mitros, T.; Salamov, A.;
Carpenter, M.; et al. The Trichoplax genome and the nature of placozoans. Nature 2008, 454, 955–960. [CrossRef]
73. Lenarcic, B.; Ritonja, A.; Strukelj, B.; Turk, B.; Turk, V. Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is
structurally related to thyroglobulin type-1 domain. J. Biol. Chem. 1997, 272, 13899–13903. [CrossRef]
74. Irving, J.A.; Pike, R.N.; Dai, W.W.; Bromme, D.; Worrall, D.M.; Silverman, G.A.; Coetzer, T.H.T.; Dennison, C.; Bottomley, S.P.;
Whisstock, J.C. Evidence that serpin architecture intrinsically supports papain-like cysteine protease inhibition: Engineering
alpha(1)-antitrypsin to inhibit cathepsin proteases. Biochemistry 2002, 41, 4998–5004. [CrossRef] [PubMed]
75. Eszterbauer, E.; Sipos, D.; Kaján, G.L.; Szegö, D.; Fiala, I.; Holzer, A.S.; Bartošová-Sojková, P. Genetic diversity of serine protease
inhibitors in myxozoan (Cnidaria, Myxozoa) fish parasites. Microorganisms 2020, 8, 1502. [CrossRef] [PubMed]
76. Geadkaew, A.; Kosa, N.; Siricoon, S.; Grams, S.V.; Grams, R. A 170 kDa multi-domain cystatin of Fasciola gigantica is active in the
male reproductive system. Mol. Biochem. Parasit. 2014, 196, 100–107. [CrossRef] [PubMed]
77. Pol, E.; Bjork, I. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine
proteinases. Biochemistry 1999, 38, 10519–10526. [CrossRef] [PubMed]
78. Jerala, R.; Kroon-Zitko, L.; Kopitar, M.; Popovic, T.; Turk, V. Deletion of the carboxy terminal part of stefin B does not have a
major effect for binding to papain. Biomed. Biochim. Acta 1991, 50, 627–629. [PubMed]
79. Hewitson, J.P.; Grainger, J.R.; Maizels, R.M. Helminth immunoregulation: The role of parasite secreted proteins in modulating
host immunity. Mol. Biochem. Parasit. 2009, 167, 1–11. [CrossRef]
80. Vendelova, E.; de Lima, J.C.; Lorenzatto, K.R.; Monteiro, K.M.; Mueller, T.; Veepaschit, J.; Grimm, C.; Brehm, K.; Hrčková, G.;
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